Neil C. Josephson

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma

J. Connors, K. Savage, Y. Oki, 2017, The New England journal of medicine.

Long‐acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study

C. Hermans, D. Perry, M. Ozelo, 2015, British journal of haematology.